01445nam 2200421 a 450 991069250960332120040713154826.0(CKB)5470000002354363(OCoLC)55899688ocm55899688(OCoLC)995470000002354363(EXLCZ)99547000000235436320040713d2000 ua 0enguran||||||txtrdacontentcrdamediacrrdacarrierPrescription drugs[electronic resource] many factors affected FDA's approval of selected "pipeline" drugs : report to congressional requesters[Washington, D.C.] :U.S. General Accounting Office,[2000]Title from title screen (viewed on July 6, 2004)."August 2000."Paper version available from: U.S. General Accounting Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548."GAO/HEHS-00-140."Includes bibliographical references.Prescription drugs Patent medicinesUnited StatesPatent extensionsUnited StatesDrugsUnited StatesTestingPatent medicinesPatent extensionsDrugsTesting.GPOGPOBOOK9910692509603321Prescription drugs2884258UNINA